Skip to main content
2026 CRT Conference Main banner

Charles S. Love, MA

Chief Science Officer
Jupiter Endovascular Inc
Menlo Park, California, United States

Charles S. Love is Chief Scientific Officer at Jupiter Endovascular, where he leads the company’s strategic development, clinical research strategy, and advanced project initiatives for the Vertex™ Transforming Fixation (TFX) catheter platform. With more than three decades of experience in cardiovascular and endovascular innovation, he has played a central role in the development, financing, and clinical translation of multiple medical technologies across structural heart and vascular intervention. At Jupiter, Mr. Love works closely with leading investigators and international research centers to advance novel catheter-based therapies for pulmonary embolism, pulmonary hypertension, and structural heart disease.

Disclosure(s): Jupiter Endovascular Inc: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)

Presentation(s):

Email Charles